Bloomberg News
@Bloomberg-News·2.8M subscribers·40.1K videos
Moderna’s Covid Vaccine Receives Full Approval From U.S. FDA
Posted
January 31, 2022
Views
1,013
Likes
16
Comments
6
Engagement
January 31, 2022
1,013
16
6
2.17%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:18Now PlayingModerna Inc.’s vaccine for Covid-19 received full approval from the U.S. Food and Drug Administration for people 18 and older, an important milestone that bolsters the shot’s use as a major weapon against the virus.
The vaccine, which goes by the brand name Spikevax, had previously been available to adults in the U.S. under an emergency use authorization from the FDA. But the full clearance lets Moderna market the vaccine to adults with the full imprimatur of the FDA.
Subscribe to our YouTube channel
Subscribe to our newest channel Quicktake Explained
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
